Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model

Journal of Biological Chemistry

Volumn 289, Issue 42, 2014, Pages 28827-28834

  Zhou, Xiang ^a   Feng, Yu ^a   Zhan, Zhoubing ^a   Chen, Jianchang ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION;

CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; GLOMERULAR BASEMENT MEMBRANE; MATRIX DEPOSITION; RENAL FUNCTIONS; RENAL INTERSTITIAL FIBROSIS; RENIN-ANGIOTENSIN SYSTEM; STREPTOZOTOCIN;

DISEASES;

CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE; NITROGEN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UREA; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG MECHANISM; ENZYME INHIBITION; GLOMERULUS BASEMENT MEMBRANE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY FUNCTION; MESANGIUM CELL; NONHUMAN; OXIDATIVE STRESS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UREA NITROGEN BLOOD LEVEL; ANIMAL; BASEMENT MEMBRANE; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; FIBROSIS; KIDNEY; MALE; MESANGIUM; METABOLISM; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC; SPRAGUE DAWLEY RAT;

ANIMALS; BASEMENT MEMBRANE; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FIBROSIS; GLOMERULAR MESANGIUM; HYDROGEN SULFIDE; INFLAMMATION; KIDNEY; MALE; MESANGIAL CELLS; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM; STREPTOZOCIN;

EID: 84908042345     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.596593     Document Type: Article

References (20)

1. Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S., and Danesh, F. R. (2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. 233, 4-11
2. Sun, Y. M., Su, Y., Li, J., and Wang, L. F. (2013) Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochem. Biophys. Res. Commun. 433, 359-361
3. Kanwar, Y. S., Sun, L., Xie, P., Liu, F. Y., and Chen, S. (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu. Rev. Pathol. 6, 395-423
4. Aminzadeh, M. A., and Vaziri, N. D. (2012) Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. Nephrol. Dial. Transplant. 27, 498-504
5. Song, K., Wang, F., Li, Q., Shi, Y. B., Zheng, H. F., Peng, H., Shen, H. Y., Liu, C. F., and Hu, L. F. (2014) Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy. Kidney Int. 85, 1318-1329
6. Kashihara, N., Haruna, Y., Kondeti, V. K., and Kanwar, Y. S. (2010) Oxidative stress in diabetic nephropathy. Curr. Med. Chem. 17, 4256-4269
7. Stanton, R. C. (2011) Oxidative stress and diabetic kidney disease. Curr. Diab. Rep. 11, 330-336
8. Wada, J., and Makino, H. (2013) Inflammation and the pathogenesis of diabetic nephropathy. Clin. Sci. 124, 139-152
9. Navarro-González, J. F., Mora-Fernández, C., Muros de Fuentes, M., and García-Pérez, J. (2011) Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat. Rev. Nephrol. 7, 327-340
10. Forbes, J. M., Coughlan, M. T., and Cooper, M. E. (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57, 1446-1454
11. Lim, A. K., and Tesch, G. H. (2012) Inflammation in diabetic nephropathy. Mediators Inflamm. 2012, 146154
12. Kaspar, J. W., Niture, S. K., and Jaiswal, A. K. (2009) Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic. Biol. Med. 47, 1304-1309
13. Saito, H. (2013) Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases. Biochem. Pharmacol. 85, 865-872
14. Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., Moreno, J. A., Santamaria, B., Ruiz-Ortega, M., Egido, J., and Ortiz, A. (2010) NF-κB in renal inflammation. J. Am. Soc. Nephrol. 21, 1254-1262
15. Napetschnig, J., and Wu, H. (2013) Molecular basis of NF-κB signaling. Annu. Rev. Biophys. 42, 443-468
16. Wolf, G., and Ziyadeh, F. N. (1999) Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 56, 393-405
17. Kawano, H., Kim, S., Ohta, K., Nakao, T., Miyazaki, H., Nakatani, T., and Iwao, H. (2003) Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression. J. Am. Soc. Nephrol. 14, 584-592
18. Gurley, S. B., and Coffman, T. M. (2007) The renin-angiotensin system and diabetic nephropathy. Semin. Nephrol. 27, 144-152
19. Carey, R. M., and Siragy, H. M. (2003) The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol. Metab. 14, 274-281
20. Remuzzi, G., Perico, N., Macia, M., and Ruggenenti, P. (2005) The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int. Suppl. 99, S57-S65